Volume 158, Issue 3 supplement

Search all European Journal of Pediatrics articles

December 1999

Filter by

Volume:

Sort by

Date published:

New to old Old to new

29 articles in this issue

Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey
R. Sträter
H. Vielhaber
U. Nowak-Göttl
THROMBOPHILIA Pages: S122 - S125
Hemothorax under thrombolytic therapy with recombinant tissue
V. Varnholt
H. Ringe
G. Gaedicke
THROMBOPHILIA Pages: S140 - S142
Heparin-induced thrombocytopenia in paediatric patients – a review of the literature and a new case treated with danaparoid sodium
Oliver Ranze
Petra Ranze
Andreas Greinacher
THROMBOPHILIA Pages: S130 - S133
Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines
R. Knöfler
E. Siegert
M. Kabus
THROMBOPHILIA Pages: S147 - S150
Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer
R. Mertens
H. Brost
U. Nowak-Göttl
THROMBOPHILIA Pages: S154 - S158
Prevalence and outcome of intracranial haemorrhage in haemophiliacs – a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)
J. Klinge
K. Auberger
the paediatric group of the German Society of Thrombosis and Haemostasis
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S162 - S165
Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: Is there a clinical relevance?
F. Kertzscher
A. E. Müller
H. Lenk
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S177 - S179
A 2-year-old boy with recurrent severe bleeding: von Willebrand type 2B and ITP – or von Willebrand type 2B alone?
R. Rauch
U. Budde
J. Klinge
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S171 - S173
Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?
R. von Kries
A. Hachmeister
U. Göbel
VITAMIN K Pages: S183 - S186
Systemic meningococcal infection: Which children may benefit from adjuvant haemostatic therapy? Results from an observational study
W. Nürnberger
R. v. Kries
U. Göbel
CONSUMPTION COAGULOPATHY AND DIC Pages: S192 - S196
Anticoagulant response to Agkistrodon Contortrix venom (ACV) in infants and children with genetic defects in the protein C anticoagulant pathway
A. Kirschbaum
R. Junker
U. Nowak-Göttl
LABORATORY INVESTIGATIONS Pages: S203 - S204
Plasma values for u-PA in children
P. Zeitler
V. Schuster
LABORATORY INVESTIGATIONS Pages: S205 - S208
Prothrombotic risk factors in childhood stroke and venous thrombosis
C. Heller
S. Becker
W. Kreuz
THROMBOPHILIA Pages: S117 - S121
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis – Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
R. Schobess
R. Junker
U. Nowak-Göttl
THROMBOPHILIA Pages: S105 - S108
Coagulation-associated complications of indwelling arterial and central venous catheters during heparin prophylaxis – a prospective study
R. Hentschel
U. Wiescholek
G. Jorch
THROMBOPHILIA Pages: S126 - S129
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters
C. Wermes
M. Depka Prondzinski
K.-W. Sykora
THROMBOPHILIA Pages: S143 - S146
The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases
N. Nohe
A. Flemmer
K. Auberger
THROMBOPHILIA Pages: S134 - S139
The course of fibrinolytic proteins in children with malignant bone tumours
U. Nowak-Göttl
N. Münchow
S. Ehrenforth
THROMBOPHILIA Pages: S151 - S153
Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report
C. Wermes
F. Bergmann
K.-W. Sykora
THROMBOPHILIA Pages: S159 - S161
When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study
H. Pollmann
H. Richter
H. Jürgens
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S166 - S170
Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy
C. Escuriola Ettingshausen
I. Martinez Saguer
W. Kreuz
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S180 - S182
DDAVP treatment in a child with von Willebrand disease type 2M
C. Mauz-Körholz
U. Budde
U. Göbel
HAEMOPHILIA AND VON WILLEBRAND DISEASE Pages: S174 - S176
Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency – A feasibility pilot study
W. D. Kreuz
W. Schneider
U. Nowak-Göttl
CONSUMPTION COAGULOPATHY AND DIC Pages: S187 - S191
Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma
S. Becker
W. Schneider
U. Nowak-Göttl
CONSUMPTION COAGULOPATHY AND DIC Pages: S197 - S202
Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-Trimoxazole
A. Müller
F. Kertzscher
H. Lenk
LABORATORY INVESTIGATIONS Pages: S209 - S210
The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis
H. G. Koch
P. Nabel
U. Nowak-Göttl
THROMBOPHILIA Pages: S113 - S116
Role of genetic prothrombotic risk factors in childhood caval vein thrombosis
N. Münchow
A. Kosch
U. Nowak-Göttl
THROMBOPHILIA Pages: S109 - S112
Abstracts
Pages: S211 - S220
Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood
S. Ehrenforth
R. Junker
for the Childhood Thrombophilia Study Group
THROMBOPHILIA Pages: S97 - S104

Volume 158, Issue 3 supplement

Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey

Hemothorax under thrombolytic therapy with recombinant tissue

Heparin-induced thrombocytopenia in paediatric patients – a review of the literature and a new case treated with danaparoid sodium

Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines

Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer

Prevalence and outcome of intracranial haemorrhage in haemophiliacs – a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)

Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: Is there a clinical relevance?

A 2-year-old boy with recurrent severe bleeding: von Willebrand type 2B and ITP – or von Willebrand type 2B alone?

Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?

Systemic meningococcal infection: Which children may benefit from adjuvant haemostatic therapy? Results from an observational study

Anticoagulant response to Agkistrodon Contortrix venom (ACV) in infants and children with genetic defects in the protein C anticoagulant pathway

Plasma values for u-PA in children

Prothrombotic risk factors in childhood stroke and venous thrombosis

Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis – Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation

Coagulation-associated complications of indwelling arterial and central venous catheters during heparin prophylaxis – a prospective study

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters

The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases

The course of fibrinolytic proteins in children with malignant bone tumours

Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report

When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study

Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy

DDAVP treatment in a child with von Willebrand disease type 2M

Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency – A feasibility pilot study

Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma

Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-Trimoxazole

The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis

Role of genetic prothrombotic risk factors in childhood caval vein thrombosis

Abstracts

Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood

Navigation